The phosphoinositide 3-kinase (PI3K) pathway is a crucial signal ... of PI3K or through loss of the PTEN tumour suppressor. Inhibitors that target key components of this pathway, including PI3K ...

The off-label use of JAK inhibitors to treat JDM is common in pediatric rheumatology, with barriers to use including limited clinical trial data and insurance approval.